Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 5
2005 10
2006 7
2007 6
2008 8
2009 8
2010 9
2011 6
2012 7
2013 12
2014 4
2015 3
2016 5
2017 6
2018 4
2019 3
2020 7
2021 4
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Cancer vaccines.
Schiller JT, Lowy DR, Frazer IH, Finn OJ, Vilar E, Lyerly HK, Gnjatic S, Zaidi N, Ott PA, Balachandran VP, Dietrich PY, Migliorini D, Vonderheide RH, Domchek SM. Schiller JT, et al. Among authors: finn oj. Cancer Cell. 2022 Jun 13;40(6):559-564. doi: 10.1016/j.ccell.2022.05.015. Cancer Cell. 2022. PMID: 35700704 Free PMC article.
Cancer immunoprevention.
Finn OJ, Beatty PL. Finn OJ, et al. Curr Opin Immunol. 2016 Apr;39:52-8. doi: 10.1016/j.coi.2016.01.002. Epub 2016 Jan 19. Curr Opin Immunol. 2016. PMID: 26799207 Free PMC article. Review.
Cancer immunology.
Melief CJ, Finn OJ. Melief CJ, et al. Among authors: finn oj. Curr Opin Immunol. 2011 Apr;23(2):234-6. doi: 10.1016/j.coi.2011.01.003. Epub 2011 Feb 1. Curr Opin Immunol. 2011. PMID: 21292460 No abstract available.
Cancer immunology.
Finn OJ. Finn OJ. N Engl J Med. 2008 Jun 19;358(25):2704-15. doi: 10.1056/NEJMra072739. N Engl J Med. 2008. PMID: 18565863 Review. No abstract available.
Beneficial autoimmunity improves cancer prognosis.
Zitvogel L, Perreault C, Finn OJ, Kroemer G. Zitvogel L, et al. Among authors: finn oj. Nat Rev Clin Oncol. 2021 Sep;18(9):591-602. doi: 10.1038/s41571-021-00508-x. Epub 2021 May 11. Nat Rev Clin Oncol. 2021. PMID: 33976418 Review.
Prophylactic cancer vaccines.
Finn OJ, Forni G. Finn OJ, et al. Curr Opin Immunol. 2002 Apr;14(2):172-7. doi: 10.1016/s0952-7915(02)00317-5. Curr Opin Immunol. 2002. PMID: 11869888 Review.
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.
Schoen RE, Boardman LA, Cruz-Correa M, Bansal A, Kastenberg D, Hur C, Dzubinski L, Kaufman SF, Rodriguez LM, Richmond E, Umar A, Szabo E, Salazar A, McKolanis J, Beatty P, Pai RK, Singhi AD, Jacqueline CM, Bao R, Diergaarde B, McMurray RP, Strand C, Foster NR, Zahrieh DM, Limburg PJ, Finn OJ. Schoen RE, et al. Among authors: finn oj. Clin Cancer Res. 2023 May 1;29(9):1678-1688. doi: 10.1158/1078-0432.CCR-22-3168. Clin Cancer Res. 2023. PMID: 36892581 Free PMC article. Clinical Trial.
The dawn of vaccines for cancer prevention.
Finn OJ. Finn OJ. Nat Rev Immunol. 2018 Mar;18(3):183-194. doi: 10.1038/nri.2017.140. Epub 2017 Dec 27. Nat Rev Immunol. 2018. PMID: 29279613 Review.
114 results